SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma

SS Innovations’ SSi Mantra Surgical Robotic System Approved for Use in Indonesia

SS Innovations’ SSi Mantra Surgical Robotic System Approved for Use in Indonesia

GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Extension of Agreement with PeaceHealth Sacred Heart Medical Center at RiverBend

Extended 10-year Agreement to Upgrade Gamma Knife® PerfexionTM with Elekta Esprit

GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Extension of Agreement with PeaceHealth Sacred Heart Medical Center at RiverBend

Rodedawg (OTC: RWGI) Expands into Dispensary Acquisitions and Signs Letter of Intent for Dispensary License

Company Moves into Retail Dispensary Markets for Proprietary Branding & Strengthening Distribution

Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers

Rodedawg (OTC: RWGI) Announces Successful Launch of Nutrient CBD Product Line

New Orders Begin with Company Completion of Wholesale, Affiliate, Retail Website

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte’s VitaGraft Study

SS Innovations Engages BDO as its new Auditor

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

Clinical testing of LP-310 expected to commence in mid-2024 - Patient recruitment is underway for Phase 2a multicenter, dose-ranging study

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus